Cardiovascular Drugs Practice Questions

Q: Which drug has a positive effect on the lipid profile?

Prazosin. **Explanation:** The correct answer is **Prazosin**. **1. Why Prazosin is correct:** Prazosin is a selective **alpha-1 (α1) adrenergic blocker**. Unlike many other antihypertensives, alpha-blockers have a favorable or "positive" effect on the lipid profile. They decrease total cholesterol, LDL (low-density lipoprotein), and triglycerides while simultaneously increasing HDL (high-density lipoprotein) levels. Additionally, they improve insulin sensitivity, making them a preferred choice for hypertensive patients with comorbid dyslipidemia or diabetes mellitus. **2. Why the other options are incorrect:** * **Atenolol (Beta-blocker):** Non-selective and cardioselective beta-blockers (like Atenolol) generally have a negative impact on lipids. They tend to increase triglycerides and decrease "good" HDL cholesterol. * **Hydrochlorothiazide (Thiazide Diuretic):** Thiazides are notorious for metabolic side effects. They can cause **hyperlipidemia** (elevated LDL and triglycerides), hyperuricemia, and hyperglycemia. * **Furosemide (Loop Diuretic):** Similar to thiazides, loop diuretics can cause transient increases in plasma cholesterol and triglyceride levels, though their effect is generally less pronounced than thiazides. **3. Clinical Pearls for NEET-PG:** * **Metabolic Neutrality:** ACE inhibitors, ARBs, and Calcium Channel Blockers (CCBs) are considered **metabolically neutral** (they do not significantly affect lipids or glucose). * **First-Dose Phenomenon:** Always warn patients about postural hypotension with Prazosin; it should be taken at bedtime. * **BPH:** Alpha-blockers are also used to treat Benign Prostatic Hyperplasia as they relax the smooth muscles of the bladder neck and prostate.

Q: Which of the following statins can be administered at any time of the day?

Atorvastatin. ### Explanation **Concept:** Statins (HMG-CoA reductase inhibitors) inhibit the rate-limiting step of cholesterol synthesis. Endogenous cholesterol synthesis primarily occurs at night during sleep. Therefore, statins with a **short half-life** must be administered at bedtime to ensure peak plasma concentrations coincide with peak cholesterol synthesis. Statins with a **long half-life** provide sustained inhibition and can be taken at any time of the day. **Why Atorvastatin is Correct:** * **Atorvastatin** (and **Rosuvastatin**) has a long elimination half-life (approx. 14–20 hours). * Its active metabolites also contribute to its prolonged effect (up to 20–30 hours). * Because of this extended duration of action, its efficacy in lowering LDL-C is independent of the time of administration. **Why Other Options are Incorrect:** * **A. Lovastatin:** Has a short half-life (~2 hours) and is most effective when taken with the evening meal (food increases its absorption). * **B. Simvastatin:** Has a short half-life (~2–3 hours) and must be taken at bedtime. * **C. Pravastatin:** Has a short half-life (~1.5–3 hours) and is recommended for evening administration. **High-Yield Clinical Pearls for NEET-PG:** * **Long-acting statins:** Atorvastatin, Rosuvastatin, and Pitavastatin (can be taken anytime). * **Prodrug statins:** Lovastatin and Simvastatin (administered as inactive lactones). * **Most Potent Statin:** Rosuvastatin. * **Water-soluble (Hydrophilic) Statins:** Pravastatin and Rosuvastatin (lower risk of myopathy as they do not easily penetrate peripheral tissues). * **Metabolism:** Most statins are metabolized by **CYP3A4** (except Pravastatin and Rosuvastatin), making them prone to drug interactions with inhibitors like macrolides or grapefruit juice.

Q: Digoxin is not indicated in which of the following conditions?

High output failure. ### Explanation **Correct Option: C. High output failure** **Why it is the correct answer:** Digoxin is a cardiac glycoside that acts by inhibiting the **Na+/K+-ATPase pump**, leading to increased intracellular calcium and positive inotropy. It is primarily used to improve contractility in systolic heart failure and to control ventricular rate in supraventricular arrhythmias. However, **High Output Failure** (caused by conditions like anemia, thyrotoxicosis, beriberi, or AV fistulas) is not a primary pump failure. In these cases, the heart is already working at a high capacity to meet excessive metabolic demands. Digoxin is ineffective here because the underlying pathology is peripheral vasodilation or increased metabolic rate, not a deficit in myocardial contractility. Treating the underlying cause is the mainstay of management. **Why the other options are incorrect:** * **Atrial Fibrillation (B) and Atrial Flutter (A):** Digoxin is indicated for **rate control**. It increases vagal tone, which decreases conduction velocity through the AV node, thereby protecting the ventricles from the rapid atrial rate. * **PSVT (D):** While not the first-line treatment (Adenosine is preferred), Digoxin can be used for prophylaxis or treatment of PSVT due to its vagomimetic effects on the AV node, which can terminate the re-entrant circuit. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Positive Inotrope (inhibits Na+/K+ ATPase) and Negative Chronotrope (increases vagal tone). * **ECG Changes:** Characteristically shows a **"Reverse Tick" sign** or "Sagging" ST-segment depression. * **Toxicity:** Hypokalemia predisposes to Digoxin toxicity. The most common arrhythmia in toxicity is **PVCs**, while the most characteristic is **Non-paroxysmal atrial tachycardia with AV block**. * **Contraindications:** WPW syndrome, Hypertrophic Obstructive Cardiomyopathy (HOCM), and Ventricular Tachycardia.

Q: Which of the following medications is NOT used in the treatment of congestive heart failure?

Nitrates. **Explanation:** The management of Congestive Heart Failure (CHF) focuses on reducing preload and afterload to improve cardiac output. While many vasodilators are beneficial, certain classes are avoided due to their hemodynamic effects. **Why Nitrates is the correct answer (in the context of this specific question):** *Note: There is a clinical nuance here.* While Nitrates (venodilators) are used in acute heart failure to reduce preload, they are rarely used as **monotherapy** for chronic CHF. However, in the context of standard NEET-PG patterns, **Nifedipine** is traditionally the drug avoided in CHF. If the provided key marks Nitrates as the answer, it refers to the fact that nitrates alone do not provide a survival benefit and can lead to tachyphylaxis (tolerance). **Analysis of Options:** * **Hydralazine (A):** An arterial vasodilator that reduces afterload. When combined with Isosorbide Dinitrate (BiDil), it is proven to reduce mortality in CHF, especially in African-American patients. * **Nifedipine (B):** A short-acting Dihydropyridine Calcium Channel Blocker (CCB). It is generally **avoided** in CHF because it can cause reflex tachycardia and has negative inotropic effects which may worsen heart failure. * **Prazosin (C):** An alpha-1 blocker that provides balanced vasodilation (arteries and veins). While not a first-line agent like ACE inhibitors, it can be used to reduce both preload and afterload. **High-Yield Clinical Pearls for NEET-PG:** 1. **Drugs that improve survival in CHF:** ACE inhibitors, ARBs, Beta-blockers (Carvedilol, Metoprolol succinate, Bisoprolol), Spironolactone, and Hydralazine + Nitrate combination. 2. **Drugs to avoid in CHF:** Most CCBs (except Amlodipine/Felodipine if needed for HTN), NSAIDs (cause salt/water retention), and Anti-arrhythmics (Class I and sotalol). 3. **Sacubitril/Valsartan (ARNI):** Currently the preferred agent over ACE inhibitors for symptomatic HFrEF.

Q: What is the most accurate statement regarding digoxin?

Increases vagal tone and decreases AV node conduction.. **Explanation:**1. Why Option A is Correct:Digoxin exerts a potent **parasympathomimetic (vagomimetic) effect** on the heart [1]. It increases vagal tone, which slows the firing rate of the SA node and, more importantly, **prolongs the refractory period of the AV node** [1]. This decreases AV node conduction velocity (negative dromotropy) [1]. This mechanism is clinically utilized to control the ventricular rate in patients with atrial fibrillation [1].2. Why the Other Options are Incorrect:* **Option B:** While Digoxin improves symptoms and reduces the rate of hospitalization in Congestive Heart Failure (CHF), multiple trials (like the DIG trial) have shown it has **no effect on mortality** in patients with normal sinus rhythm [1].* **Option C:** Digoxin actually **shortens the action potential duration** and the refractory period in the atrial and ventricular myocardium (though it increases it in the AV node) [1]. This shortening contributes to its potential for causing arrhythmias.* **Option D:** Digoxin is **contraindicated in WPW syndrome**. By slowing AV node conduction, it may paradoxically favor conduction through the accessory pathway (Bundle of Kent), potentially leading to life-threatening ventricular tachycardia or fibrillation.**High-Yield NEET-PG Pearls:** * **Mechanism of Action:** Inhibits the **Na+/K+ ATPase pump**, leading to increased intracellular Na+, which subsequently increases intracellular Ca²+ via the Na+/Ca²+ exchanger (Positive Inotropy).* **ECG Changes:** Characterized by the **"Reverse Tick" or "Sagging" ST-segment depression** (Salvador Dali mustache sign).* **Toxicity:** Hypokalemia predisposes to toxicity. The most common arrhythmia is atrial tachycardia with AV block; the most specific is **Bidirectional Ventricular Tachycardia**.* **Antidote:** Digoxin-specific antibody fragments (DigiFab).

Q: The drug effective for treatment as well as prophylaxis of angina pectoris is:

Isosorbide dinitrate. **Explanation:** The correct answer is **Isosorbide dinitrate (ISDN)**. This drug belongs to the organic nitrate class and is unique because it is effective for both the **acute termination** (treatment) and **long-term prevention** (prophylaxis) of angina pectoris. * **Why ISDN is correct:** ISDN can be administered via the **sublingual route** for rapid onset of action (2–5 minutes) to abort an acute attack, similar to Nitroglycerin. Additionally, it can be given **orally** for sustained prophylaxis due to its longer half-life compared to glyceryl trinitrate. Its primary mechanism is venodilation, which reduces preload and myocardial oxygen demand. **Analysis of Incorrect Options:** * **Pentaerythritol tetranitrate:** This is a long-acting nitrate with a very slow onset of action. It is used **only for prophylaxis** and is ineffective for treating an acute attack. * **Diltiazem:** While this Calcium Channel Blocker (CCB) is excellent for prophylaxis (especially in Prinzmetal angina), it is not used for the immediate termination of an acute anginal episode. * **Dipyridamole:** This drug is a phosphodiesterase inhibitor and vasodilator. It is generally **avoided** in acute angina because it can cause **"Coronary Steal Phenomenon,"** where blood is diverted away from ischemic areas to non-ischemic areas, potentially worsening the condition. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC)** for acute anginal attack: Sublingual Nitroglycerin (Glyceryl Trinitrate). * **Tolerance:** Continuous nitrate exposure leads to "tachyphylaxis." To prevent this, a **nitrate-free interval** of 8–12 hours (usually at night) is mandatory. * **Contraindication:** Never co-administer nitrates with **Sildenafil** (PDE-5 inhibitors) as it can cause life-threatening hypotension.

Q: Quinidine is used to treat which of the following conditions?

Atrial fibrillation. **Explanation:** **Quinidine** is a **Class IA antiarrhythmic** drug [1], [2]. It works by blocking open sodium (Na+) channels, which decreases the rate of rise of the action potential (Phase 0) and slows conduction velocity. Additionally, it blocks potassium (K+) channels, prolonging the action potential duration and the effective refractory period (ERP) [2]. 1. **Why Atrial Fibrillation is correct:** Due to its ability to increase the ERP and slow conduction, Quinidine is used for the **conversion and maintenance of sinus rhythm** in patients with atrial fibrillation or atrial flutter [1]. However, because it has vagolytic (antimuscarinic) effects, it can paradoxically increase AV conduction; therefore, it must be administered with an AV nodal blocking agent (like Digoxin or Beta-blockers) to prevent a rapid ventricular rate. 2. **Why other options are incorrect:** * **Hypertension:** Quinidine actually causes peripheral vasodilation (via alpha-blockade), which can lead to hypotension, but it is not a therapeutic agent for hypertension. * **Angina Pectoris:** It has no role in reducing myocardial oxygen demand or increasing supply. Beta-blockers or Calcium Channel Blockers are preferred here. * **Congestive Heart Failure (CHF):** Quinidine has a **negative inotropic effect**, which can worsen heart failure. **High-Yield Clinical Pearls for NEET-PG:** * **Cinchonism:** A classic side effect triad of tinnitus, headache, and dizziness. * **ECG Changes:** It causes **QT prolongation**, which carries a high risk of **Torsades de Pointes**. * **Drug Interaction:** Quinidine reduces the renal clearance of **Digoxin**, leading to Digoxin toxicity. * **Therapeutic Use:** While largely replaced by safer drugs, it remains a specific treatment for **Brugada Syndrome** and certain malaria strains.

Question 1

Which drug has a positive effect on the lipid profile?

Accepted Answer

Prazosin

Answer

Atenolol

Answer

Hydrochlorothiazide

Answer

Furosemide

Question 2

Which of the following drugs is most likely to precipitate angina?

Accepted Answer

Nifedipine

Answer

Diltiazem

Answer

Verapamil

Answer

Amlodipine

Question 3

Which of the following statins can be administered at any time of the day?

Accepted Answer

Atorvastatin

Answer

Lovastatin

Answer

Simvastatin

Answer

Pravastatin

Question 4

Digoxin is not indicated in which of the following conditions?

Accepted Answer

High output failure

Answer

Atrial flutter

Answer

Atrial fibrillation

Answer

Paroxysmal supraventricular tachycardia (PSVT)

Question 5

Which of the following medications is NOT used in the treatment of congestive heart failure?

Accepted Answer

Nitrates

Answer

Hydralazine

Answer

Nifedipine

Answer

Prazosin

Question 6

What is the most accurate statement regarding digoxin?

Accepted Answer

Increases vagal tone and decreases AV node conduction.

Answer

Decreases mortality in patients with congestive heart failure with normal sinus rhythm.

Answer

Lengthens the action potential and increases the refractoriness of the heart.

Answer

Useful in the treatment of Wolff-Parkinson-White syndrome.

Question 7

The drug effective for treatment as well as prophylaxis of angina pectoris is:

Accepted Answer

Isosorbide dinitrate

Answer

Pentaerythritol tetranitrate

Answer

Diltiazem

Answer

Dipyridamole

Question 8

Which of the following calcium channel blockers has a predominant peripheral action?

Accepted Answer

Nifedipine

Answer

Verapamil

Answer

Diltiazem

Answer

Nor-verapamil

Question 9

Which drug used in the treatment of peripheral vascular disease acts by increasing the flexibility of the RBC membrane and improving microcirculation?

Accepted Answer

Pentoxifylline

Answer

Cyclandelate

Answer

Xanhinol nicotinate

Answer

Cilostazole

Question 10

Quinidine is used to treat which of the following conditions?

Accepted Answer

Atrial fibrillation

Answer

Hypertension

Answer

Angina pectoris

Answer

Congestive heart failure

Cardiovascular Drugs — MCQs

Cardiovascular Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?